Seagen’s License and Co-Development Agreement with RemeGen

Seagen's License and Co-Development Agreement with RemeGen
Martina Bellini North America, North America Legal Chronicle

Fenwick & West advised Seagen on the deal while O’Melveny & Myers represented RemeGen Co. Seagen Inc. (Nasdaq: SGEN), a world leader and pioneer in antibody-drug…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:
Martina Bellini

Author: Martina Bellini

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here